This content is machine translated Type 2 diabetes: insulin therapy - quo vadis? Basic insulin with once-weekly injection convinces An ultra-long-acting insulin analogue that only needs to be injected once a week is currently in development. The results of the clinical studies to date are promising. Insulin Icodec has…
View Post 4 min This content is machine translated European Diabetes Congress in Stockholm First antidiabetic drug with proven reduction in cardiovascular risk Some 15,600 people from 134 countries attended the 51st European Diabetes Conference in Stockholm (Annual Meeting of the European Association for the Study of Diabetes). The results of the EMPA-REG…
